prostanoids , especially prostacyclin and thromboxane , through their effects on vascular endothelium , platelet function , and interaction with lipoproteins , are postulated to be centrally involved in the pathogenesis of atherosclerosis .
C0033567
prostacyclin
C0003850
atherosclerosis